
Adverum Biotechnologies, Inc. (ADVM) Dividend History
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company focused on developing treatments for serious ophthalmic diseases. The company's approach involves using gene therapy to address unmet medical needs, aiming to provide long-term solutions for conditions such as wet age-related macular degeneration and diabetic macular edema. Founded in 2014, Adverum emphasizes innovation in its pursuit to restore or preserve vision through its proprietary delivery platforms.
Dividend History
Adverum Biotechnologies, Inc. currently does not pay dividends